Beam Therapeutics Inc.
Beam Therapeutics Inc.（BEAM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
beam · 股价预测 · 27 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 27 位华尔街分析师
Buy
27 位分析师
共识
评级分布
12 个月目标价
High
$80.00
Consensus
$48.00
+63.3% upside
Low
$26.00
Median: $40 · Last Close: $29.40
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$48.00
63.3% upside
High Target
$80
172.1%
Low Target
$26
-11.6%
Current Price
$29.40
as of today
Based on analyst price targets, the BEAM stock price prediction for the next 12 months ranges from $26 to $80. The consensus BEAM price forecast of $48.00 implies 63.3% upside from the current price of $29.40.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $29.62 | ↑ 0.74% |
1-day model range: $29.33–$29.9. Peak: $29.9 (+0.74%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $19 | -34.0% |
| 2028 | $15 | -47.4% |
| 2029 | $14 | -53.8% |
| 2030 | $13 | -57.2% |
| 2031 | — | -59.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BEAM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Bernstein | Maintains | Outperform→Outperform |
| 2026-03-26 | Citigroup | Maintains | Buy→Buy |
| 2026-02-25 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-25 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2026-01-21 | Bernstein | Maintains | Outperform→Outperform |
| 2025-10-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-09 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-06 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2025-05-07 | Barclays | Maintains | Equal Weight→Equal Weight |
Wall Street analysts have recently issued updated ratings on Beam Therapeutics Inc. (BEAM) stock. Of the recent 94 rating actions, 10 were upgrades and 8 were downgrades. 27 analysts currently cover BEAM.
分析师推荐趋势
BEAM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$71M
↓ 47.6% YoY
Revenue Next Year
$79M
↑ 10.9% YoY
EPS This Year
$-4.42
EPS Next Year
$-4.59
↑ 3.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast BEAM EPS of $-4.42 for the current fiscal year, based on estimates from 12 analysts. The BEAM revenue forecast is $71M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BEAM 股价预测由两类独立数据源支撑：来自 27 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BEAM 的共识目标价为 $48.00（+63.3% 上行空间），分析师共识为 Buy。
BEAM 的短期预测（明日）为 $29.62（+0.74%）。 BEAM 对 2027 年的股价预测均值为 $19。 BEAM 对 2030 年的预测区间为 $11–$14。
Beam Therapeutics Inc. 在 NASDAQ 上市，代码 BEAM。BEAM 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。
常见问题
BEAM 预测 · 8 个问题根据 27 位华尔街分析师，BEAM 的 12 个月平均目标价为 $48.00，最高 $80.00、最低 $26.00。若有图表，中位目标价可在上方查看。相对当前价 $29.40，隐含约 +63.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.